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Abstract 
Background: Malaria in pregnancy poses a major public health problem in Indonesia with an estimated six million 
pregnancies at risk of Plasmodium falciparum or Plasmodium vivax malaria annually. In 2010, Indonesia introduced 
a screen and treat policy for the control of malaria in pregnancy at first antenatal visit using microscopy or rapid 
diagnostic tests (RDTs). A diagnostic study was conducted in Sumba, Indonesia to compare the performance of four 
different RDTs in predominately asymptomatic pregnant women under field condition.
Methods: Women were screened for malaria at antenatal visits using field microscopy and four HRP-2/pLDH combi-
nation RDTs (Carestart™, First-Response®, Parascreen® and SD-Bioline®). The test results were compared with expert 
microscopy and nested PCR. End user experience of the RDTs in the field was assessed by questionnaire.
Results: Overall 950 were recruited and 98.7 % were asymptomatic. The prevalence of malaria was 3.0–3.4 % by RDTs, 
and 3.6, 5.0 and 6.6 % by field microscopy, expert microscopy and PCR, respectively. The geometric-mean parasite 
density was low (P. falciparum = 418, P. vivax = 147 parasites/µL). Compared with PCR, the overall sensitivity of the 
RDTs and field microscopy to detect any species was 24.6–31.1 %; specificities were >98.4 %. Relative to PCR, First-
Response® had the best diagnostic accuracy (any species): sensitivity = 31.1 %, specificity = 98.9 % and diagnostic 
odds ratio = 39.0 (DOR). The DOR values for Carestart™, Parascreen®, SD-Bioline®, and field microscopy were 23.4, 
23.7, 23.5 and 29.2, respectively. The sensitivity of Pan-pLDH bands to detect PCR confirmed P. vivax mono-infection 
were 8.6–13.0 %. The sensitivity of the HRP-2 band alone to detect PCR confirmed P. falciparum was 10.3–17.9 %. Pan-
pLDH detected P. falciparum cases undetected by the HRP-2 band resulting in a better test performance when both 
bands were combined. First Response® was preferred by end-users for the overall practicality.
Conclusion: The diagnostic accuracy to detect malaria among mostly asymptomatic pregnant women and per-
ceived ease of use was slightly better with First-Response®, but overall, differences between the four RDTs were small 
and performance comparable to field microscopy. Combination RDTs are a suitable alternative to field microscopy to 
screen for malaria in pregnancy in rural Indonesia. The clinical relevance of low density malaria infections detected by 
PCR, but undetected by RDTs or microscopy needs to be determined.
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Background
Malaria in pregnancy poses a major public health prob-
lem in Indonesia, where annually an estimated 6.3 million 
pregnancies are potentially at risk of Plasmodium falci-
parum or Plasmodium vivax malaria [1] and the corre-
sponding risk of malaria associated maternal anaemia and 
low birth weight due to pre-term delivery or intra-uterine 
growth retardation [2–4]. Early detection and effective 
management of asymptomatic and symptomatic malaria 
is essential to reduce the burden of malaria in pregnancy.
Indonesia introduced a screen and treat policy for the 
control of malaria in pregnancy in 2010 [5]. It consists of 
screening all pregnant women for malaria at their first 
antenatal visit using microscopy or rapid diagnostic test 
(RDT), regardless of the presence or absence of symp-
toms. At subsequent antenatal visits, testing for malaria 
is done only in women with symptoms of malaria. 
Malaria positive women are treated with artemisinin-
based combination therapy (ACT, dihydroartemisinin–
piperaquine), except in the first trimester when quinine is 
used. Microscopy, remains the gold standard for malaria 
diagnosis in most health facilities. RDTs are used in the 
village based antenatal clinics.
The common immuno-chromatography based malaria 
RDTs detect the histidine rich protein-2 (HRP-2) antigen 
or parasite lactate dehydrogenase (pLDH) enzyme. The 
HRP-2/pLDH combination RDTs are commonly used 
in Indonesia and other Asian countries where multiple 
Plasmodium species are endemic. The HRP-2 antigen 
is specific for P. falciparum and Pan-pLDH detects all 
human infecting species [6, 7].
RDTs are essential for the success of the malaria in 
pregnancy screening programme. Numerous studies 
have shown the ability of HRP-2 based RDTs to detect P. 
falciparum in symptomatic population in areas of vary-
ing transmissions [8–13]. Few studies have evaluated 
RDTs in pregnancy [14–16] and fewer as a screening test 
in pregnant women [17–20], specially to detect P. vivax 
in asymptomatic women [21–23], and under field con-
ditions. The study aimed to assess the ability of RDTs 
to detect P. falciparum and P. vivax, in mostly asymp-
tomatic pregnant women and to compare it against the 
performance of standard field microscopy. For this, a 
cross-sectional study was conducted in eastern Indonesia 
comparing four combination RDTs and field microscopy 
against expert microscopy and PCR to identify the RDT 
with highest diagnostic accuracy and field practicality to 
use as a screening test in rural antenatal clinics.
Methods
Study area and facilities
The study was conducted between March and July 2012 
in south-west Sumba district in eastern Indonesia where 
malaria transmission is low and seasonal and varies sub-
stantially across sub-districts [24]. Prevalence of malaria 
in the general population (all age groups) in the rainy sea-
son (December–March) is 6.8 % with a predominance of 
P. falciparum. In the dry season (April–November) both 
P. falciparum and P. vivax are present in equal propor-
tions with an overall prevalence of 4.9 % by PCR.
The study was conducted in ‘Posyandus’, which are vil-
lage based community integrated activities held monthly 
that include provision of outreach antenatal care services 
provided by the primary health centres (Puskesmas). A 
total of 45 Posyandus were involved in the study, served 
by four Puskesmas in the sub-districts of Bondo-Kodi, 
Kori, Wallandimu and Pannengo-ede, each covering a 
catchment population of approximately 30,000 people 
and 10–11 villages.
Participant enrolment
Pregnant women of any gravidity aged between 15 and 
49  years who attended the Posyandu for routine ante-
natal care were enrolled. A questionnaire consisting 
of socio-demographic information, obstetric history, 
history of fever and drug use, including malaria pre-
vention measures was completed and the axillary tem-
perature recorded. A finger prick blood sample was taken 
to simultaneously test the four RDTs, malaria microscopy 
and dried blood spots for PCR. Women testing positive 
for malaria with any RDT were treated according to the 
national policy which was a 3 day course of ACT (dihy-
droartemisinin–piperaquine) in the second and third tri-
mester and 7 days of oral quinine in the first trimester.
Microscopy
Thick and thin smears were made on the same slide and 
stained with 5  % Giemsa. For the ‘field microscopy’, the 
smears were read by the staff microscopist at each of the 
four Puskesmas who were unaware of the RDT results. 
Thin smears were used to identify species. Expert micros-
copy consisted of re-examination of all the slides by the 
senior microscopist at the Malaria Laboratory-1, Eijkman 
Institute in Jakarta, who was blinded to field microscopy 
and RDT results. In cases of disagreement between field 
and expert microscopy, PCR result was taken as final. A 
slide was declared negative if parasites were absent after 
examining 200 high power fields. Parasite density was 
quantified against 300 leukocytes on an assumed leu-
kocyte count of 8000 per µL of blood. Sub-microscopic 
infection was defined as parasites detected by PCR, but 
not by expert microscopy or RDT respectively.
Rapid diagnostic tests
The four RDTs included Parascreen Rapid Test Pan/
Pf® (Zephyr Biomedical System, India, Catalogue No: 
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50310025), SD Bioline Malaria Ag Pf/Pan® (Standard 
Diagnostic Inc. Suwon City, South Korea, Catalogue No: 
05FK60), the two RDTs used in the malaria control pro-
gramme in Indonesia at the time of the study, and First 
Response Malaria pLDH/HRP-2 combo® (Premier Medi-
cal Corporation Ltd, India, Catalogue No: l16FRC30) and 
CareStart Malaria pLDH/HRP2 combo™ (Access Bio Inc., 
NJ, USA, Catalogue No: G0131), two of the best perform-
ing RDTs indicated in the WHO/FIND round 1–3 report 
[25]. Trained study staff performed and interpreted the 
RDTs according to the manufacturer’s instructions.
Accordingly, four drops of buffer were used for SD 
Bioline® and read within 15  min; for the other three 
RDTs two drops of buffer were used and was read within 
20 min. Malaria positivity was defined if any of the HRP-2 
or pLDH bands were visible (plus the control band). If 
only HRP-2 band plus control band was visible it was 
considered as a P. falciparum infection and visibility of 
only Pan-pLDH band was considered a P. vivax infection. 
When both bands were positive simultaneously it was 
considered a P. falciparum infection or a mixed infection.
Polymerase chain reaction
Nested PCR was performed on all samples to detect 
malaria parasites and for speciation. A blood sample 
was spotted on Whatman grade-1 filter paper, air-dried, 
placed in a plastic bag and transported to Jakarta. DNA 
was extracted with a 20 % Chelex solution and stored at 
−20  °C. Nested PCR based on the principle described 
by Snounou et  al. [26] was used for genus and species 
specific analysis of P. falciparum and P. vivax. All ribo-
somal PCR positives samples were confirmed using mito-
chondrial DNA based PCR. Repeat mitochondrial PCR 
was performed for discordant P. vivax samples using 
KAPA2G™ Fast ReadyMix (2×) (KAPA Bio systems) 
containing all components for the PCR and the prim-
ers MitoPf-F 307 and MitoPf-R 5904 and adding 2 µL of 
DNA template. Species identification was done on PCR-
Restriction Fragment Length Polymorphism (Rflp) using 
the restriction endonuclease enzyme Acl1. The amplicon 
was electrophoresed on 2 % agarose gel and the species 
specific DNA bands were viewed. Staff unaware of the 
microscopy and the RDT results performed PCR.
Quality control measures and RDT transport and storage
Room temperature and humidity in the RDT storage 
rooms in the Puskesmas were monitored and recorded 
using Tinytag™ Data Loggers with alarms set at 40  °C, 
the upper limit of temperature stability for SD Bioline®. 
The recorded data was saved into the main database and 
verified fortnightly. The maximum humidity recorded 
was 82.1 rh % and temperature ranged between 22.8 and 
28.5  °C during the study period. To follow real-life field 
situations, environmental conditions in storage facilities 
were not controlled although excessive exposure to direct 
sunlight was avoided during RDT transportation. Indi-
vidual kits were opened only at the time of testing and 
were checked for the presence of the desiccant. A single 
batch of each RDT with same LOT number purchased 
directly from the manufacturer was used.
End user experience
The ease of use and practicality of the study RDTs in 
the field situation was explored mid-way of the study. 
The Puskesmas midwives/nurses trained for the study 
were given a questionnaire to assess the readability and 
print clarity of information on the package exterior, 
ease of using the blood collecting devices, transferring 
blood to the RDT cassette and addition of buffer drops. 
Each parameter was scaled from easy, moderately easy 
and hard and the response frequency to each category 
calculated.
Sample size
A sample size of 940 pregnant women were estimated to 
be sufficient to compare RDTs with expert microscopy 
and PCR. Allowing for a 10 % loss of samples or unsuc-
cessful tests a target sample size of 1045 women was 
estimated. An anticipated malaria prevalence of 10  % 
detectable by PCR was considered with reference to a 
previous study in the area [27]. This assumption would 
allow the detection of a sensitivity and specificity of 
0.97 with a lower 95  % confidence limit >0.9 with 95  % 
probability.
Statistical analysis
Data were double entered and verified using XAMPP 
Windows 1.7.7. Frequencies and proportions were cal-
culated using SPSS version 20.0. The results of the four 
RDTs and field microscopy were first compared against 
expert microscopy as the reference test. In subsequent 
analysis the RDTs, field and expert microscopy were 
compared against PCR (all samples) as the reference 
test, for any species (overall) and by specific RDT bands 
(HRP-2 and pLDH) against the species identified by PCR. 
For both sets of analyses, the sensitivity, specificity, posi-
tive and negative predictive values and likelihood ratios 
(LR) were calculated with corresponding 95 % confidence 
intervals (CI) using an online calculator which uses the 
efficient score method to calculate 95  % CI suitable for 
situations where the proportion is small and prevalence 
is low [28]. The diagnostic odds ratio (DOR) was used 
as a single summary indicator of test effectiveness inde-
pendent of prevalence combining sensitivity and specific-
ity, where DOR was defined as the ratio of the odds of 
positivity in those with malaria (defined by PCR or expert 
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microscopy) relative to the odds of positivity in those 
without malaria. The DOR is also the ratio of the positive 
and negative likelihood ratio (LR+/LR−) [29].
Ethical approval
The study was approved by the Research and Ethi-
cal Committees of the Eijkman Institute for Molecular 
Biology, Indonesia and the Liverpool School of Tropical 
Medicine, UK. Written informed consent was obtained.
Results
A total of 950 women who attended the study Posyandus 
for antenatal care were enrolled between March and July 
2012. Most women were indigenous to southwest Sumba 
(97.5 %) and lived in rural areas (100 %). Their mean age 
(SD) was 28.8 (6.2) years and 17.8  % were primigravi-
dae. The proportion of women reporting ownership of 
long lasting insecticide treated nets (LLINs) was 29.9  % 
of whom 93.3  % reported to have slept under the net 
the previous night. A documented fever (≥37.5  °C) was 
present in 12 of 949 women (1.3  %) and 157 (16.5  %) 
reported a history of fever in the previous week of whom 
31 (19.7 %) reported taking anti-malarial drugs.
Malaria prevalence detected by RDTs, microscopy and PCR
Overall a full set of results for the RDTs, blood smears 
and PCR samples were available from 934 of the 950 
women. The remaining 16 women (1.7 %) were excluded 
from analysis because not all four RDT tests were suc-
cessful or no microscopy results were available.
Malaria positivity by RDT (HRP2 or pLDH) ranged 
from 3.0  % (28 women) with Carestart™ to 3.4  % (32 
women) with Parascreen® (Table 1). The higher number 
of positives with Parascreen® relative to Carestart™ was 
due to a higher number of positives by the HRP-2 band 
(21 versus 15). Overall, differences in results were great-
est for the single Pan-pLDH band (which in the absence 
of a positive HRP-2 band is indicative of non-falciparum 
malaria infections) and positivity varied from 6.6 % with 
SD Bioline® to 21.4 % with Carestart™.
There were 34 (3.6 %) and 47 (5.0 %) malaria (any spe-
cies) positives detected by field and expert microscopy 
respectively when both asexual and sexual stages were 
considered. Overall, 5 of the 34 (14.7 %) and 8 of the 47 
(17.0 %) were positive for gametocytes by field and expert 
microscopy respectively. Expert microscopy detected 
5 (10.6  %) mono infections with Plasmodium malariae 
and 5 (10.6  %) mixed infections with P. falciparum and 
P. vivax.
Overall infection prevalence by PCR was 6.6 % (all spe-
cies) and 3.9 % were sub-patent infections (microscopy or 
RDT negative). Of the 62 positives identified by PCR, 39 
(62.9 %) were with P. falciparum (32 mono-infections and 
seven mixed with P. vivax), and 23 (37.0 %) were P. vivax 
mono-infections. No infections with P. malariae were 
detected.
There were 31 women who had reported to have taken 
antimalarial drug in the previous week. Out of these, one 
women had all four RDTs positives, two women had a 
positive microscopy (6.4 %) and three women had a posi-
tive PCR (9.6 %) for any malaria.
Discriminating ability of the RDTs and field microscopy
PCR as reference test
Malaria overall (any species) (Table  2): The sensitivity 
and specificity of the RDTs to detect malaria (any species) 
(positive HRP-2 or Pan-pLDH band) against PCR was 
relatively similar for all four RDTs. The sensitivity ranged 
between 25.8 and 32.3 %. The specificity was >98.3 % for 
all RDTs. First Response® had the highest combination 
of sensitivity and specificity, reflected in the highest LR-
positive, lowest LR-negative scores and the highest DOR 
value (41.0, 95 % CI 16.9–101.2). The DOR of Carestart™ 
(24.9), Parascreen® (−25.0) and SD Bioline® (24.9) were 
similar. The sensitivity of field microscopy was compara-
ble to First Response®, but the specificity and the DOR 
(29.1) was lower.
Plasmodium falciparum and single HRP-2 band 
(Table  3): The performance of the HRP-2-bands alone 
(i.e. ignoring the results of the Pan-pLDH band) to detect 
P. falciparum infections assessed by PCR, showed that 
the overall sensitivity ranged from 10.3 % with Carestart™ 
to 17.9  % with Parascreen® and First Response®. The 
PPV and DOR indices were highest for First Response® 
reflected by less false positives compared to other RDTS.
Plasmodium falciparum and single Pan-pLDH band 
(Table 4): The accuracy of pLDH band alone to detect P. 
falciparum was assessed against PCR detected mono- P. 
falciparum (after exclusion of P. vivax mono or mixed 
infection from the analysis). The sensitivity ranged from 
18.8 % with Parascreen® to 25.0 % with First Response®. 
The DOR was highest for SD Bioline® followed by First 
Response®.
Plasmodium falciparum and the combined HRP-2 and 
Pan-pLDH bands (Table 5): The accuracy of HRP-2 and 
pLDH positive bands to detect P. falciparum was evalu-
ated with PCR confirmed P. falciparum (any). The sensi-
tivities ranged between 30.7 and 41.0 %. The LR positive 
and DOR values ranged between 17.2 and 24.5  % for 
Carestart™ and 26.2 and 44.4  % for First Response®, 
respectively.
Plasmodium vivax and Pan-pLDH band (Table  6): 
The performance of RDT to detect P. vivax was evalu-
ated with PCR detected P. vivax mono-infections (after 
exclusion of P. falciparum mono or mixed infection from 
the analysis). The sensitivity to detect P. vivax was lower 
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than for P. falciparum ranging from 8.7 % with SD Bio-
line® to 13.0 % with the other three RDTs. The DOR val-
ues ranged from 10.8 % with SD Bioline® to 16.9 % with 
Parascreen®. The field microscopy indices were relatively 
better for P. vivax detection with higher DOR values.
Expert microscopy as reference test
Similar results were found when RDTs and field micros-
copy were compared against expert microscopy to detect 
any malaria (Table  2). Overall, the sensitivity remained 
modest for all four RDTs and for field microscopy with 
SD Bioline® scoring better LR-positive and DOR values. 
When the ability to detect P. falciparum by HRP-2 band 
was assessed, First Response® had a lower false positive 
score reflected by higher PPV and LR-positive relative to 
the other RDTs (Table 3). SD Bioline® indices to detect P. 
vivax by pLDH band were relatively better than the other 
RDTs.
RDT detection of malaria at different parasite densities
The geometric mean parasite density of P. falciparum 
assessed by expert microscopy was 418 parasites/µL 
(range 27–13,387 parasites/uL) and of P. vivax was 147 
parasites/µL (range 27–5733 parasites/µL). Out of the 12 
PCR confirmed expert microscopy positive P. falciparum 
cases, there was one case of mono-infection with P. falci-
parum at density <100 parasite/µL and this was negative 
by all four RDTs. Similarly, there were 6 cases out of the 
11 P. vivax PCR confirmed positives which has densi-
ties of <100 parasites/µL detected by expert microscopy; 
none were detected by the RDTs (Fig.  1). The ability to 
detect low-density P. falciparum infections (101–499/
μL) was comparable between Carestart™ (6/6) and First 
Response® (6/6) relative to Parascreen® and SD Bioline®. 
The detection of low-density P. vivax infections (100–
499/μL) was similar in all RDTs (33.3 %).
End user experience
The user practicality of the RDTs was evaluated among 
all the 50 study midwives/nurses performing RDTs in the 
study. Most respondents cited the pipette of SD Bioline® 
was the easiest to draw blood with (86.0  %) (Table  7), 
but to add blood into a sample well and for the overall 
ease of use of pipette, First Response® scored 88.0 and 
96.0  % respectively followed by SD Bioline®. The least 
easy pipette to draw and dispense blood with was that 
Table 1 Malaria detected by the four RDTs (HRP-2 and pLDH bands), microscopy and PCR
Pf, P. falciparum; Pv, P. vivax
a Sub-microscopic = expert microscopy negative, PCR positive
Carestart™ First Response® Parascreen® SD Bioline®
n = 934 n = 934 n = 934 n = 934
RDT positive (any band) n (%) 28 (3.0) 30 (3.2) 32 (3.4) 30 (3.2)
HRP-2 band only, n (%) 15 (53.6) 17 (56.6) 21 (65.6) 20 (66.6)
P. falciparum confirmed by PCR
 HRP-2 band, n (%) 4 (26.7) 7 (41.2) 7 (33.3) 6 (30.0)
Pan-pLDH band only, n (%) 6 (21.4) 6 (19.4) 4 (12.5) 2 (6.6)
Species confirmed by PCR
 P. falciparum, n (%) 2 (33.0) 3 (50.0) 1 (25.0) 1 (50.0)
 P. vivax, n (%) 2 (33.0) 2 (33.0) 2 (50.0) 1 (50.0)
 Negative 2 (33.0) 1 (16.9) 1 (25.0) 0
HRP2 + pLDH bands, n (%) 7 (25.0) 7 (23.0) 7 (21.8) 8 (26.6)
Species confirmed by PCR
 P. falciparum, n (%) 5 (71.4) 5 (71.4) 5 (71.4) 6 (75.0)
 P. vivax, n (%) 1 (14.3) 1 (14.3) 1 (14.3) 1 (12.5)
 Mixed (Pf + Pv), n (%) 1 (14.3) 1 (14.3) 1 (14.3) 1 (12.5)
Field microscopy Expert microscopy PCR n = 934
n = 934 n = 934 Overall Sub-microscopica
Parasitaemia any, n (%) 34 (3.6) 47 (5.0) 62 (6.6) 32 (3.4)
P. falciparum, n (%) 26 (76.5) 24 (51.1) 32 (51.6) 20 (62.5)
P. vivax, n (%) 8 (23.5) 13 (27.7) 23 (37.0) 12 (37.5)
P. malariae, n (%) – 5 (10.6) – –
Mixed (Pf + Pv) n (%) – 5 (10.6) 7 (11.3) –
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of Parascreen®. All respondents found the buffer bot-
tles comparatively easy to use and add the right amount 
of drops. First Response® scored highest for overall ease 
of use, whereas SD Bioline® scored highest for clarity 
and readability of printed information provided with the 
RDT.
Discussion
The performance of SD Bioline®, Carestart™, First 
Response® and Parascreen® RDTs to screen mostly 
asymptomatic antenatal women for malaria were evalu-
ated in four sub-districts of South west Sumba, Indone-
sia as a potential alternative to field microscopy. Overall 
the diagnostic accuracy, suggested that First Response® 
RDT had the best combined ability to detect both P. fal-
ciparum and P. vivax infections when compared against 
PCR. The diagnostic odds ratio (DOR) value for First 
Response®, as a single summary indicator of test perfor-
mance, was lower than that observed for expert micros-
copy but higher than the 23–29 DOR values observed for 
the other RDTs. First Response® was also considered the 
easiest to use by the clinic staff. Nevertheless, the over-
all differences in performance of the four RDTs to detect 
malaria were small and importantly, comparable to field 
microscopy. Any of the four brands would probably be 
suitable as a potential alternative to field microscopy or 
for use in the clinics where microscopy is not available.
However, of note was the low sensitivity (26–32  %) 
of all four RDTs (and field microscopy) relative to PCR, 
which detected 2–3 additional infections for each infec-
tion detected by RDT. These findings are consistent with 
the known limitations of this current generation of RDTs 
and highlight the challenge of applying them as a screen-
ing test in asymptomatic pregnant women who on aver-
age will have much lower parasite densities when infected 
than symptomatic malaria patients, the intended popula-
tion for whom most RDTs are used. The geometric mean 
parasite densities in those with detectable parasites by 
expert microscopy were low for both species, especially 
for P. vivax (418 parasites/µL for P. falciparum and 147 
parasites/µL for P. vivax by expert microscopy). None of 
the infections (any species) below 100 parasites/µL were 
detected by RDTs, around the threshold level of detec-
tion for many RDTs [25].
The sensitivity was also low when compared against 
expert microscopy (43.0–47.0 %, any species) and lower 
than reported in previous studies in asymptomatic preg-
nant women during pregnancy and at delivery [13]. In 
addition to the low mean parasite densities mentioned 
above, other methodological differences could explain 
Table 2 Accuracy indices of  the RDTs and  Field microscopy compared with  expert microscopy and  PCR to  detect any 
malaria (HRP-2 or pLDH band; P. falciparum or P. vivax)
TP true positive, FP false positive, FN false negative, TN true negative, PPV positive predictive value, NPV negative predictive value, LR likelihood ratio, DOR diagnostic 
odds ratio
Carestart™ First Response® Parascreen® SD Bioline® Field microscopy Expert microscopy
Expert microscopy as reference test
TP, FP 20, 8 21, 9 21, 11 22, 8 21, 13 N/A
FN, TN 27, 879 26, 878 26, 876 25, 879 26, 874
Sensitivity (95 % CI) 42.6 (31.5–50.9) 44.7 (33.4–53.5) 44.6 (30.4–59.7) 46.8 (35.6–55.1) 44.7 (32.9–54.9)
Specificity (95 % CI) 99.1 (98.5–99.5) 99.0 (98.4–99.5) 98.7 (97.7–99.3) 99.1 (98.5–99.5) 98.5 (97.9–99.1)
PPV (95 % CI) 71.4 (52.9–85.4) 70.0 (52.3–83.8) 65.6 (46.7–80.8) 73.3 (55.8–86.3) 61.8 (45.5–75.8)
NPV (95 % CI) 97.0 (96.4–97.5) 97.1 (96.5–97.6) 97.1 (95.7–98.0) 97.2 (96.7–86.3) 97.1 (96.5–97.6)
LR positive (95 % CI) 47.2 (21.2–110.3) 44.0 (20.7–97.3) 36.0 (18.4–70.3) 51.9 (23.8–119.4) 30.4 (15.7–59.3)
LR negative (95 % CI) 0.58 (0.49–0.69) 0.56 (0.47–0.67) 0.56 (0.43–0.72) 0.54 (0.45–0.65) 0.56 (0.46–0.68)
DOR (95 % CI) 81.4 (30.5–223.4) 78.7 (30.6–207.9) 64.3 (26.3–168.8) 96.7 (36.4–264.7) 54.3 (27.9–130.1)
PCR as the reference test
TP, FP 16, 12 20, 10 18, 14 17, 13 20, 14 30, 17
FN, TN 46, 860 42, 862 44, 858 45, 859 42, 858 32, 855
Sensitivity (95 % CI) 25.8 (15.8–38.7) 32.3 (21.2–45.4) 29.0 (18.5–42.1) 27.4 (17.2–40.4) 32.2 (17.2–40.4) 48.4 (35.6–61.3)
Specificity (95 % CI) 98.6 (97.5–99.2) 98.8 (97.8–99.4) 98.3 (97.2–99.0) 98.5 (97.3–99.1) 98.3 (97.2–99.0) 98.0 (96.8–98.8)
PPV (95 % CI) 57.1 (37.4–74.9) 66.6 (47.1–82.0) 56.2 (37.8-73.1) 56.6 (37.6–74.0) 58.8 (40.8–74.8) 63.8 (48.4–76.9)
NPV (95 % CI) 94.9 (93.2–96.2) 95.3 (93.7–96.5) 95.1 (93.4–96.3) 95.0 (93.3–96.3) 95.3 (93.6–96.5) 96.3 (94.8–97.4)
LR positive (95 % CI) 18.7 (9.2–37.8) 28.2 (13.7–57.4) 18.8 (9.4–34.6) 18.3 (9.3–36.1) 20.0 (10.6–37.8) 24.8 (14.5–42.4)
LR negative (95 % CI) 0.75 (0.65–0.87) 0.68 (0.57–0.81) 0.72 (0.61–0.84) 0.73 (0.63–0.85) 0.68 (0.57–0.81) 0.52 (0.41–0.69)
DOR (95 % CI) 24.9 (10.4–60.1) 41.0 (16.9–101.2) 25.0 (11.0–57.4) 24.9 (10.7–58.6) 29.1 (12.9–66.1) 47.1 (22.4–100.2)
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Table 3 Accuracy indices of the HRP-2 band and Field microscopy compared with expert microscopy and PCR to detect P. 
falciparum
TP true positive, FP false positive, FN false negative, TN true negative, CI confidence interval, PPV positive predictive value, NPV negative predictive value, LR Likelihood 
ratio, DOR diagnostic odds ratio
Carestart™ First Response® Parascreen® SD Bioline® Field microscopy Expert microscopy
Expert microscopy as reference test
TP, FP 7, 8 9, 8 8, 13 9, 11 13, 13 N/A
FN, TN 17, 902 15, 902 16, 897 15, 899 11, 897
Sensitivity (95 % CI) 29.2 (13.4–51.2) 37.5 (19.6–59.2) 33.3 (16.4–55.3) 37.5 (19.6–59.2) 54.2 (33.2–73.8)
Specificity (95 % CI) 99.1 (98.2–99.6) 99.1 (98.2–99.6) 98.6 (97.5–99.2) 98.8 (97.8–99.4) 98.6 (97.5–99.2)
PPV (95 % CI) 46.7 (22.3–72.6) 52.9 (28.5–76.1) 38.1 (19.0–61.3) 45.0 (23.8–67.7) 50.0 (30.4–69.6)
NPV (95 % CI) 98.2 (97.0–98.9) 98.4 (97.3–99.0) 98.2 (97.1–99.0) 98.4 (97.2–99.0) 98.8 (97.8–99.4)
LR positive (95 % CI) 33.2 (13.1–84.1) 42.7 (18.0–101.0) 23.3 (10.7–51.0) 31.0 (14.2–67.8) 37.9 (19.7–72.9)
LR negative (95 % CI) 0.71 (0.55–0.92) 0.63 (0.46–0.86) 0.68 (0.51–0.90) 0.63 (0.46–0.86) 0.46 (0.30–0.72)
DOR (95 % CI) 46.4 (13.3–163.3) 67.7 (20.4–228.7) 34.5 (11.2–105.7) 49.0 (15.9–152.9) 81.5 (30.0–243.0)
PCR as the reference test
TP, FP 4, 11 7, 10 7, 14 6, 14 12, 14 12, 12
FN, TN 35, 884 32, 885 32, 881 33, 881 27, 881 27, 883
Sensitivity (95 % CI) 10.3 (3.3–25.2) 17.9 (8.1–34.1) 17.9 (8.1–34.1) 15.4 (6.4–31.2) 30.8 (17.5–47.7) 30.8 (17.5–47.7)
Specificity (95 % CI) 98.8 (97.7–99.4) 98.9 (97.9–99.4) 98.4 (97.3–99.1) 98.4 (97.3–99.1) 98.4 (97.3–99.1) 98.7 (97.6–99.2)
PPV (95 % CI) 26.7 (8.9–55.2) 41.2 (19.4–66.5) 33.3 (15.5–56.9) 30.0 (12.8–54.3) 46.2 (27.1–66.3) 50.0 (29.6–70.4)
NPV (95 % CI) 96.2 (94.7–97.3) 96.5 (95.1–97.6) 96.5 (95.0–97.6) 96.4 (94.9–97.5) 97.0 (95.6–98.0) 97.0 (95.7–98.0)
LR positive (95 % CI) 8.3 (2.8–25.0) 16.1 (6.5–40.0) 11.5 (4.9–26.8) 9.8 (4.0–24.2) 19.7 (9.8–39.7) 22.9 (11.0–47.8)
LR negative (95 % CI) 0.9 (0.82–1.01) 0.83 (0.72–0.96) 0.83 (0.72–96.5) 0.86 (0.75–0.98) 0.70 (0.57–0.87) 0.70 (0.57–0.87)
DOR (95 % CI) 9.2 (2.3–33.4) 19.4 (6.2–59.9) 13.8 (4.7–39.8) 11.4 (3.7–34.6) 30.0 (10.9–71.9) 32.7 (12.4–86.9)
Table 4 Accuracy indices of the pLDH band compared with expert microscopy and PCR to detect P. falciparum
TP true positive, FP false positive, FN false negative, TN true negative, CI confidence interval, PPV positive predictive value, NPV negative predictive value, LR likelihood 
ratio, DOR diagnostic odds ratio
Carestart™ First Response® Parascreen® SD Bioline®
Expert microscopy as the reference
TP, FP 7, 6 6, 7 6, 5 6, 4
FN, TN 17, 904 18, 903 18, 905 18, 906
Sensitivity (95 % CI) 29.2 (13.4–51.2) 25 (10.6–47.1) 25 (10.6–47.1) 25 (10.6–47.1)
Specificity (95 % CI) 99.3 (98.5–99.7) 99.2 (98.3–99.7) 99.5 (98.6–99.8) 99.6 (98.8–99.9)
PPV (95 % CI) 53.8 (26.1–79.6) 46.1 (20.4–73.9) 54.5 (24.6–81.9) 60 (27.4–86.3)
NPV (95 % CI) 98.2 (96.9–98.8) 98.0 (96.7–98.8) 98 (96.9–98.8) 98.1 (96.9–98.8)
LR positive (95 % CI) 44.2 (16.1–121.7) 32.5 (11.8–89.4) 45.5 (14.9–138.8) 56.9 (17.2–188.5)
LR negative (95 % CI) 0.71 (0.55–0.92) 0.76 (0.60–0.95) 0.75 (0.60–0.95) 0.75 (0.60–0.95)
DOR (95 % CI) 62 (16.5–239.0) 43 (11.4–162.7) 60.3 (14.5–257.2) 75.5 (16.9–356.3)
PCR as the reference
TP, FP 7, 6 8, 5 6, 5 7, 3
FN, TN 25, 896 24, 897 26, 897 25, 899
Sensitivity (95 % CI) 21.9 (9.9–40.4) 25 (12.1–43.8) 18.8 (7.9–37.0) 21.9 (9.9–40.4)
Specificity (95 % CI) 99.3 (98.4–99.7) 99.4 (98.6–99.8) 99.4 (98.6–99.8) 99.7 (98.9–99.9)
PPV (95 % CI) 53.8 (26.1–79.6) 61.5 (32.2–84.9) 54.5 (24.6–81.9) 70 (35.4–91.9)
NPV (95 % CI) 97.3 (96.0–98.2) 97.4 (96.1–98.3) 97.2 (95.8–98.1) 97.3 (96.0–98.2)
LR positive (95 % CI) 32.9 (11.7–92.3) 45.1 (15.6–130.2) 33.8 (10.9–105.1) 65.8 (17.8–242.7)
LR negative (95 % CI) 0.79 (0.65–0.94) 0.75 (0.62–0.92) 0.82 (0.69–0.97) 0.78 (0.65–0.94)
DOR (95 % CI) 41.8 (11.5–154.1) 59.8 (16.2–230.7) 41.4 (10.3–169.9) 83.9 (18.0–439.7)
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the lower sensitivity. First, the expert microscopist 
declared a slide negative after examining 200 instead of 
the commonly used 100 high power fields, thus doubling 
the volume of blood that was examined to enhance the 
sensitivity of microscopy. Second, several previous stud-
ies showed that diagnostic studies with imperfect gold 
standard such as microscopy can lead to bias, the direc-
tion of which depends on the correlation between the 
index and reference test [30]. To overcome this, some 
studies comparing RDT against microscopy use PCR as 
the resolver test. However, when PCR is conducted on 
discrepant samples only, it has potential for upward bias 
overestimating sensitivity and specificity [31–33] com-
pared to studies that also test a random sample of con-
cordant negative samples as recommended by WHO 
[34], or conduct PCR on all samples regardless of the 
Table 5 Accuracy indices of the RDTs (HRP-2 and pLDH) bands compared with PCR to detect P. falciparum
TP true positive, FP false positive, FN false negative, TN true negative, CI confidence interval, PPV positive predictive value, NPV negative predictive value, LR likelihood 
ratio, DOR diagnostic odds ratio; include positives for mixed species
Carestart First Response Parascreen SD Bioline
PCR as reference test
TP, FP 12, 16 16, 14 14, 18 14, 16
FN, TN 27, 879 23, 881 25, 887 25, 879
Sensitivity (95 % CI) 30.7 (17.5–47.7) 41.0 (25.9–57.8) 35.8 (21.6–52.8) 35.8 (21.6–52.8)
Specificity (95 % CI) 98.2 (97.0–98.9) 98.4 (97.3–99.1) 97.9 (96.7–98.7) 98.2 (97.0–98.9)
PPV (95 % CI) 42.8 (25.0–62.5) 53.3 (34.6–71.2) 43.7 (26.8–62.1) 46.6 (28.7–65.3)
NPV (95 % CI) 97.0 (95.6–97.9) 97.4 (96.1–98.3) 97.2 (95.8–98.1) 97.2 (95.8–98.1)
LR positive (95 % CI) 17.2 (8.7–33.8) 26.2 (13.8–49.8) 17.8 (9.6–33.1) 20.1 (10.6–38.1)
LR negative (95 % CI) 0.7 (0.44–1.28) 0.59 (0.46–0.78) 0.65 (0.52–0.83) 0.65 (0.52–0.82)
DOR (95 % CI) 24.5 (9.7–61.2) 44.4 (17.8–108.9) 27.3 (11.3–65.6) 30.9 (12.5–75.5)
Table 6 Accuracy indices of  the pLDH bands and  Field microscopy compared with  expert microscopy and  PCR for  the 
detection of P. vivax
TP true positive, FP false positive, FN false negative, TN true negative, CI confidence interval, PPV positive predictive value, NPV negative predictive value, LR likelihood 
ratio, DOR diagnostic odds ratio
Carestart™ First Response® Parascreen® SD Bioline® Field microscopy Expert microscopy
Expert microscopy as reference test
TP, FP 3, 10 2, 11 2, 9 2, 8 0, 8 N/A
FN, TN 19, 911 11, 910 11, 912 11, 913 13, 913
Sensitivity (95 % CI) 13.6 (3.6–36.0) 15.4 (2.7–46.3) 15.4 (2.7–46.3) 15.4 (2.7–46.3) 0
Specificity (95 % CI) 98.9 (97.9–99.4) 98.8 (97.8–99.4) 99.0 (98.1–99.5) 99.1 (98.2–99.6) 99.1 (98.2–99.6)
PPV (95 % CI) 23.1 (6.2–54.0) 15.4 (2.7–46.3) 18.2 (3.2–52.2) 20.0 (3.5–55.8) 0
NPV (95 % CI) 98.0 (96.8–98.7) 98.8 (97.8–99.4) 98.8 (97.8–99.4) 98.8 (97.8–99.4) 98.6 (97.5–99.2)
LR positive (95 % CI) 12.6 (6.6–68.3) 12.9 (3.2–52.4) 15.7 (3.8–65.9) 17.7 (4.2–75.5) 0
LR negative (95 % CI) 0.87 (0.74–1.03) 0.86 (0.68–1.08) 0.85 (0.68–1.08) 0.85 (0.67–1.07) 1 (1.0–1.0)
DOR (95 % CI) 14.4 (2.9–63.7) 15.0 (2.0–86.3) 18.4 (2.4–109.8) 20.8 (2.7–126.8) 0
PCR as the reference test
TP, FP 3, 10 3, 10 3, 8 2, 8 4, 4 11, 2
FN, TN 20, 901 20, 901 20, 903 21, 903 19, 907 12, 909
Sensitivity (95 % CI) 13.0 (3.4–34.7) 13.0 (3.4–34.7) 13.0 (3.4–34.7) 8.7 (1.5–29.5) 17.4 (5.7–39.5) 47.8 (27.4–68.9)
Specificity (95 % CI) 98.9 (97.9–99.4) 98.9 (97.9–99.4) 99.1 (98.2–99.6) 99.1 (98.2–99.6) 99.6 (98.8–99.9) 99.8 (99.1–100.0)
PPV (95 % CI) 23.1 (6.2–54.0) 23.1 (6.2–54.0) 27.3 (7.3–60.7) 20.0 (3.5–55.8) 50.0 (1.7–82.6) 84.6 (53.7–97.3)
NPV (95 % CI) 97.8 (96.6–98.6) 97.8 (96.6–98.6) 97.8 (96.6–98.6) 97.7 (96.5–98.6) 97.9 (96.8–98.7) 98.7 (97.7–99.3)
LR positive (95 % CI) 11.9 (3.5–40.3) 11.9 (3.5–40.3) 14.9 (4.2–52.4) 9.9 (2.2–44.1) 39.6 (10.6–148.7) 217.8 (51.2–927.5)
LR negative (95 % CI) 0.88 (0.75–1.03) 0.88 (0.75–0.84) 0.88 (0.75–1.03) 0.92 (0.81–1.04) 0.83 (0.69–1.00) 0.52 (0.35–0.77)
DOR (95 % CI) 13.5 (2.7–59.5) 13.5 (2.7–59.5) 16.9 (3.2–78.2) 10.8 (1.5–60.1) 47.7 (9.1–251.4) 416.6 (74.1–3087.2)
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Fig. 1 Detection of Plasmodium falciparum and Plasmodium vivax by the HRP-2 and pLDH bands at different parasite densities. a P. falciparum 
detection by HRP-2bands in PCR positive cases stratified by microscopy density. Figures above the bars are HRP-2 positive bandscorresponding to 
each parasite threshold out of the total 12 PCR versus expert microscopy confirmed P. falciparum results; excludes mixed RDT infection. b. P. vivax 
detection by pLDH band in PCR positive cases stratified by microscopy density. Figures above the bars are the pLDH bands corresponding to each 
parasite threshold out of the total 11 PCR versus expert microscopy confirmed P. vivax results; none of the PCR confirmed vivax positives had para-
site density >1000/μL; excludes mixed RDT infection
Table 7 Response frequencies of the parameters assessed for end user practicality of the four RDTs
a One response is missing for this parameter
Parameter Carestart™ First Response® Parascreen® SD Bioline®
n = 50 n = 50 n = 50 n = 50
Pipette use
 Easy to draw right amount of blood, n (%) 39 (78.0) 40 (80.0) 30 (60.0) 43 (86.0)
 Easy to dispense blood into well, n (%) 44 (88.0) 44 (88.0) 22 (44.0) 43 (86.0)
 Overall ease of use, n (%) 45 (90.0) 48 (96.0) 27 (54.0) 46 (92.0)
Buffer bottle
 Easy to dispense drops into well, n (%) 36 (72.0) 37 (74.0) 38 (76.0) 36 (72.0)
Package exterior information
 Easy to read and print clarity, n (%) 44 (88.0) 38 (76.0) 46 (92.0) 45 (90.0)
Overall ease of usea
 Easy, n (%) 36 (72.0) 40 (80.0) 37 (74.0) 41 (82.0)
 Moderately easy, n (%) 7 (14.0) 3 (6.0) 6 (12.0) 6 (12.0)
 Hard to use, n (%) 6 (12.0) 6 (12.0) 6 (12.0) 2 (4.0)
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RDT and microscopy results, as done in this study. E.g. 
if only PCR was used for the discordant RDT-microscopy 
samples in our study, the sensitivity of the RDTs against 
expert microscopy would increase from 40–50 % to 75.0–
87.0 %, comparable to findings in other low transmission 
areas such as in India where P. falciparum and P. vivax 
co-exist [10].
The sensitivity of the Pan-pLDH band to detect (PCR 
confirmed) P. vivax mono-infections (Table  6) was par-
ticularly low relative to PCR whereas field microscopy 
performed slightly better as indicated by higher DOR 
value (40 for field microscopy versus 10–12 for the Pan-
pLDH RDTs bands). Six out of 11 infections detected by 
expert microscopy had densities below 100 parasites per/
μL and none of them were detected by RDTs. The low 
parasite densities of P. vivax might explain the low sen-
sitivity of the pLDH bands to detect P. vivax. Studies in 
Myanmar and Madagascar with comparable transmis-
sion level to Indonesia also found decreased accuracy of 
Pan-pLDH to P. vivax with decreasing parasite density 
[21, 35].
Interestingly, Pan-pLDH detected P. falciparum cases 
that were negative by the HRP-2 band resulting in a bet-
ter test performance when results of both bands were 
combined (Table  5). It is not known whether genetic 
variation in P. falciparum histidine rich protein, such as 
described in parasites from the Peruvian Amazon [36], 
some of which lack PfHRP2 or PfHRP3, and the extensive 
variation observed recently as a possible cause of variable 
sensitivity of the HRP2 band among Indian P. falciparum 
parasite populations [37] exist in Indonesia and if they 
affect PfHRP concentrations.
The low parasite densities for P. vivax may also explain 
the lack of agreement between expert and field micros-
copy as none of the 8 smears classified as P. vivax by field 
microscopy (4 of which were PCR confirmed) were con-
firmed by expert microscopy, and none of the 13 P. vivax 
infections detected by expert microscopy (11 of which 
were PCR confirmed) were detected by field microscopy.
Comparison between other RDT studies in pregnancy 
and this study was problematic because of the differences 
in transmission level, endemic species, RDT brands and 
analysis method used. Earlier studies have used RDTs to 
diagnose placental malaria at delivery [15, 16, 38]. Most 
African studies have used HRP-2 based RDTs to diag-
nose malaria in pregnancy and assessed for P. falcipa-
rum detection [39–41]. Other studies that used RDTs to 
screen pregnant women have used different brands at dif-
ferent transmission settings [18, 20].
To qualify for an effective screening test used in low 
malaria prevalent population, the RDTs should have an 
acceptable balance to “rule-out” and “rule-in” infections 
in asymptomatic women. The RDTs demonstrated these 
qualities for any malaria detection and their performance 
overall (any species) was similar to field microscopy. The 
high specificity and NPV indicated that the RDTs cor-
rectly identified non-infected women, which would avoid 
treating women without malaria.
The perceived ease of use by the field staff for the four 
RDTs were comparable. When the package readability 
was accounted for, SD Bioline® was favoured whereas 
First Response® was preferred for overall practicality 
including ease of blood transfer pipette and buffer usage. 
The loop pipette for blood transferring found in Par-
ascreen® kit was preferred least, similar to studies else-
where [42]. A very useful advantage of the RDTs over 
microscopy was that women could be shown the RDT 
results, which made the RDTs more acceptable to asymp-
tomatic women and which is likely to enhance compli-
ance with any 3-day ACT regimen required to treat the 
malaria infection.
Limitations of our study included the cross sectional 
study design, which limited determining when sub-
microscopic infections may become patent and we were 
unable to follow women until delivery to correlate ante-
natal RDT findings with placental malaria. Batch quality 
Lot testing prior to using the RDTs was not performed. 
The study environment with dedicated research staff 
who were trained for the study and attention given to 
operational conditions, might not reflect the routine field 
situations.
Conclusions
The diagnostic accuracy to detect malaria among mostly 
asymptomatic pregnant women and perceived ease of use 
by field staff was slightly better with First Response®, but 
overall differences between the four RDTs were small and 
performance was comparable to field microscopy. Best 
test performance to detect P. falciparum was achieved 
by combining the results of both pLDH and the HRP-2 
bands. Combination RDTs are a suitable alternative to 
field microscopy to screen for malaria in pregnancy in 
rural Indonesia. However both RDTs and field micros-
copy missed many infections detected by PCR, espe-
cially P. vivax infections. The clinical relevance of these 
low density infection needs to be determined further, as 
it may help determine whether preventive strategies such 
as intermittent preventive therapy in pregnancy (IPTp) 
may be more effective than single or repeated screening 
with RDTs during pregnancy.
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